|
시장보고서
상품코드
2024834
좌심방이 폐색 기기 시장 보고서 : 제품별, 최종 사용자별, 지역별(2026-2034년)Left Atrial Appendage Closure Devices Market Report by Product (Endocardial LAA Devices, Epicardial LAA Devices), End User (Hospitals, Ambulatory Surgery Centers, and Others), and Region 2026-2034 |
||||||
세계의 좌심방이 폐색 기기 시장 규모는 2025년에 20억 달러에 이르렀습니다. 2034년까지 73억 달러에 이르고, 2026-2034년 CAGR 14.91%를 나타낼 것으로 예측했습니다. 심방세동(AFib)의 유병률 증가, 심혈관 질환(CVD)에 취약한 고령 인구 증가, 지속적인 제품 발전과 혁신이 시장을 이끄는 주요 요인 중 일부입니다.
좌심방이 폐색 기기(LAAC)는 비판막성 심방세동(AFib) 환자의 뇌졸중 위험을 줄이기 위해 심장에 이식하는 의료기기입니다. 좌심방(LAA)은 심장의 심근벽에 있는 작은 주머니 모양의 구조물로 혈전의 발생원이며, AFib 환자의 뇌졸중을 유발할 수 있습니다. LAAC 장치는 LAA를 영구적으로 폐쇄하여 혈전 형성을 방지하고 뇌졸중 위험을 감소시키도록 설계되었습니다. 보통 팔이나 살서제에 작은 절개를 통해 카테터를 삽입하는 최소침습(MI) 수술로 이식합니다. 이 장치는 항응고제를 복용할 수 없거나 항응고제로 인한 출혈 합병증 위험이 높은 심방세동 환자들 사이에서 널리 보급되고 있습니다.
좌심방이 폐색 기기 시장 동향 :
건강에 해로운 식습관, 흡연, 음주, 좌식 생활습관의 확산으로 인한 심방세동(AFib)의 유병률 증가가 세계 시장 성장을 주도하고 있습니다. 여기에 심혈관 질환(CVD)에 취약한 고령 인구 증가, 심방세동에 따른 위험과 합병증에 대한 소비자의 우려 증가, 그리고 대체 치료 옵션이 있다는 인식이 확산되면서 시장 성장을 견인하고 있습니다. 또한, 폐색 기기의 안전성과 유효성에 대한 기술적 진보와 회복 기간 단축 및 환자 편의성 향상을 위한 저침습적 폐색 기기 개발에 대한 관심이 높아지면서 시장에는 수익성 높은 성장 기회를 가져다주고 있습니다. 이와 함께 전기생리학적 시술의 출현과 더불어 중재적 치료 및 진단 경로의 획기적인 개선이 시장 성장에 기여하고 있습니다. 또한, 의료 인프라의 급속한 확장, 의료 서비스 접근성 향상, 저침습적 폐색 기기의 인기 급상승, 각국 정부의 다양한 인식 개선 캠페인 및 상환 정책 마련 등이 시장 확대에 기여하고 있습니다. 또한, 제품 혁신을 위한 광범위한 연구개발(R&D) 활동, 심방중재술 제품 승인 건수 증가, 임상시험 증가, 로봇 보조 폐색 기기와 같은 신기술 채택 등이 시장 성장에 긍정적인 영향을 미치고 있습니다.
본 보고서에서 답변을 얻을 수 있는 주요 질문 :
- 세계의 좌심방이 폐색 기기 시장은 지금까지 어떤 추세를 보여 왔으며, 향후 몇 년 동안 어떻게 변화할 것인가?
- 세계의 좌심방이 폐색 기기 시장 성장 촉진요인, 억제요인 및 기회는?
- 각 성장 촉진요인, 제약 요인 및 기회는 세계의 좌심방이 폐색 기기 시장에 어떤 영향을 미칩니 까?
- 주요 지역 시장은?
- 가장 매력적인 좌심방이 폐색 기기 시장을 형성하고 있는 국가는 어디인가?
- 제품별로 보면, 시장 분석은 어떻게 이루어지나요?
- 좌심방이 폐색 기기 시장에서 가장 매력적인 제품은?
- 최종 사용자별 시장 현황은?
- 좌심방이 폐색 기기 시장에서 가장 매력적인 최종 사용자는 누구입니까?
- 세계의 좌심방이 폐색 기기 시장 경쟁 구도는 어떤가?
- 세계 좌심방이 폐색 기기 시장의 주요 기업은?
목차
제1장 서문
제2장 조사 범위와 조사 방법
제3장 주요 요약
제4장 서론
제5장 세계의 좌심방이 폐색 기기 시장
제6장 시장 분석 : 제품별
제7장 시장 분석 : 최종 사용자별
제8장 시장 분석 : 지역별
제9장 성장 촉진요인, 억제요인 및 기회
제10장 밸류체인 분석
제11장 Porter's Five Forces 분석
제12장 가격 분석
제13장 경쟁 구도
KTHThe global left atrial appendage closure devices market size reached USD 2.0 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 7.3 Billion by 2034, exhibiting a growth rate (CAGR) of 14.91% during 2026-2034. The escalating prevalence of atrial fibrillation (AFib), the growing geriatric population prone to cardiovascular disorders (CVDs), and ongoing product advancements and innovations represent some of the key factors driving the market.
Left atrial appendage closure devices (LAAC) are medical devices that are implanted in the heart to lower the risk of stroke in patients with non-valvular atrial fibrillation (AFib). The left atrial appendage (LAA) is a small pouch-like structure located in the muscle wall of the heart, which can be a source of blood clots, leading to stroke in AFib patients. LAAC devices are designed to permanently close off the LAA to prevent the formation of blood clots and reduce the risk of stroke. They are implanted via minimally invasive (MI) procedures, typically using a catheter that is inserted through a small incision placed in the arm or groin region. These devices are widely popular among AFib patients who cannot take anticoagulant medications or are at high risk of bleeding complications from these medications.
Left Atrial Appendage Closure Devices Market Trends:
The rising prevalence of AFib, on account of the widespread adoption of unhealthy eating habits, smoking, drinking, and sedentary lifestyles, is primarily driving the global market growth. Besides this, the growing geriatric population prone to cardiovascular disorders (CVDs), the escalating consumer concerns regarding risks and complications associated with AFib, and the expanding awareness about the availability of alternative treatment options are impelling the market growth. Moreover, significant technological advancements in closure devices in terms of the safety and efficacy of the product and the intensive emphasis on developing minimally invasive closure devices to reduce recovery time and improve patient comfort are presenting remunerative growth opportunities for the market. Concurrent with this, the advent of electrophysiology procedures, combined with considerable improvements in interventional treatments and the diagnosis pathway, is contributing to the market growth. In addition to this, rapid expansion in the healthcare infrastructure, better access to healthcare services, the surging popularity of minimally invasive closure devices, the launch of numerous awareness campaigns by governments of various countries, and the availability of reimbursement policies are aiding in market expansion. Furthermore, extensive research and development (R&D) activities for product innovation, a rising number of atrial intervention product approvals, an increasing number of clinical trials, and the adoption of new technologies, such as robotic-assisted closure devices, are positively impacting the market growth.
Key Market Segmentation:
The publisher provides an analysis of the key trends in each segment of the global left atrial appendage closure devices market, along with forecasts at the global, regional, and country levels from 2026-2034. Our report has categorized the market based on product, and end user.
Product Insights:
- Endocardial LAA Devices
- Epicardial LAA Devices
End User Insights:
- Hospitals
- Ambulatory Surgery Centers
- Others
Regional Insights:
- North America
- United States
- Canada
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for left atrial appendage closure devices. Some of the factors driving the North America left atrial appendage closure devices market included a growing number of atrial fibrillation (Afib) cases, a rise in the geriatric population, and innovative technological advancements.
Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global left atrial appendage closure devices market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Abbott Laboratories, AtriCure Inc., Boston Scientific Corporation, Cardia Inc., Lepu Medical Technology (Beijing) Co. Ltd., LifeTech Scientific, etc.
Key Questions Answered in This Report:
- How has the global left atrial appendage closure devices market performed so far, and how will it perform in the coming years?
- What are the drivers, restraints, and opportunities in the global left atrial appendage closure devices market?
- What is the impact of each driver, restraint, and opportunity on the global left atrial appendage closure devices market?
- What are the key regional markets?
- Which countries represent the most attractive left atrial appendage closure devices market?
- What is the breakup of the market based on the product?
- Which is the most attractive product in the left atrial appendage closure devices market?
- What is the breakup of the market based on the end user?
- Which is the most attractive end user in the left atrial appendage closure devices market?
- What is the competitive structure of the global left atrial appendage closure devices market?
- Who are the key players/companies in the global left atrial appendage closure devices market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Left Atrial Appendage Closure Devices Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product
- 6.1 Endocardial LAA Devices
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Epicardial LAA Devices
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
7 Market Breakup by End User
- 7.1 Hospitals
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Ambulatory Surgery Centers
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Others
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
8 Market Breakup by Region
- 8.1 North America
- 8.1.1 United States
- 8.1.1.1 Market Trends
- 8.1.1.2 Market Forecast
- 8.1.2 Canada
- 8.1.2.1 Market Trends
- 8.1.2.2 Market Forecast
- 8.1.1 United States
- 8.2 Asia-Pacific
- 8.2.1 China
- 8.2.1.1 Market Trends
- 8.2.1.2 Market Forecast
- 8.2.2 Japan
- 8.2.2.1 Market Trends
- 8.2.2.2 Market Forecast
- 8.2.3 India
- 8.2.3.1 Market Trends
- 8.2.3.2 Market Forecast
- 8.2.4 South Korea
- 8.2.4.1 Market Trends
- 8.2.4.2 Market Forecast
- 8.2.5 Australia
- 8.2.5.1 Market Trends
- 8.2.5.2 Market Forecast
- 8.2.6 Indonesia
- 8.2.6.1 Market Trends
- 8.2.6.2 Market Forecast
- 8.2.7 Others
- 8.2.7.1 Market Trends
- 8.2.7.2 Market Forecast
- 8.2.1 China
- 8.3 Europe
- 8.3.1 Germany
- 8.3.1.1 Market Trends
- 8.3.1.2 Market Forecast
- 8.3.2 France
- 8.3.2.1 Market Trends
- 8.3.2.2 Market Forecast
- 8.3.3 United Kingdom
- 8.3.3.1 Market Trends
- 8.3.3.2 Market Forecast
- 8.3.4 Italy
- 8.3.4.1 Market Trends
- 8.3.4.2 Market Forecast
- 8.3.5 Spain
- 8.3.5.1 Market Trends
- 8.3.5.2 Market Forecast
- 8.3.6 Russia
- 8.3.6.1 Market Trends
- 8.3.6.2 Market Forecast
- 8.3.7 Others
- 8.3.7.1 Market Trends
- 8.3.7.2 Market Forecast
- 8.3.1 Germany
- 8.4 Latin America
- 8.4.1 Brazil
- 8.4.1.1 Market Trends
- 8.4.1.2 Market Forecast
- 8.4.2 Mexico
- 8.4.2.1 Market Trends
- 8.4.2.2 Market Forecast
- 8.4.3 Others
- 8.4.3.1 Market Trends
- 8.4.3.2 Market Forecast
- 8.4.1 Brazil
- 8.5 Middle East and Africa
- 8.5.1 Market Trends
- 8.5.2 Market Breakup by Country
- 8.5.3 Market Forecast
9 Drivers, Restraints, and Opportunities
- 9.1 Overview
- 9.2 Drivers
- 9.3 Restraints
- 9.4 Opportunities
10 Value Chain Analysis
11 Porters Five Forces Analysis
- 11.1 Overview
- 11.2 Bargaining Power of Buyers
- 11.3 Bargaining Power of Suppliers
- 11.4 Degree of Competition
- 11.5 Threat of New Entrants
- 11.6 Threat of Substitutes
12 Price Analysis
13 Competitive Landscape
- 13.1 Market Structure
- 13.2 Key Players
- 13.3 Profiles of Key Players
- 13.3.1 Abbott Laboratories
- 13.3.1.1 Company Overview
- 13.3.1.2 Product Portfolio
- 13.3.1.3 Financials
- 13.3.1.4 SWOT Analysis
- 13.3.2 AtriCure Inc.
- 13.3.2.1 Company Overview
- 13.3.2.2 Product Portfolio
- 13.3.2.3 Financials
- 13.3.2.4 SWOT Analysis
- 13.3.3 Boston Scientific Corporation
- 13.3.3.1 Company Overview
- 13.3.3.2 Product Portfolio
- 13.3.3.3 Financials
- 13.3.3.4 SWOT Analysis
- 13.3.4 Cardia Inc.
- 13.3.4.1 Company Overview
- 13.3.4.2 Product Portfolio
- 13.3.5 Lepu Medical Technology (Beijing) Co. Ltd.
- 13.3.5.1 Company Overview
- 13.3.5.2 Product Portfolio
- 13.3.5.3 Financials
- 13.3.6 LifeTech Scientific
- 13.3.6.1 Company Overview
- 13.3.6.2 Product Portfolio
- 13.3.1 Abbott Laboratories
